MacroGenics agreed to sell its GMP manufacturing operations to Bora Pharmaceuticals in a deal designed to strengthen its ...

Silexion advances toward Phase 2/3 trial in KRAS-driven pancreatic cancer, as SIL204 begins GMP clinical manufacturing in collaboration with ...

MacroGenics to receive $122.5 million upfront payment from Bora upon closing•Transaction includes transfer of manufacturing site, CDMO ...

Our priorities for the balance of the 2026 year are clear… in the second half, we expect to initiate physician-sponsored studies in neutropenia.” (CEO & Director Handley) “In the third quarter, we ...

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today it has entered a definitive agreement with Scorpius BioManufacturing ...

ANKTIVA ® Drug Substance completed and released with two-year storage stability data sufficient for 170,000 doses of ANKTIVA product ImmunityBio’s 400,000 square foot GMP fill-finish facility in ...

The main market opportunity lies in the need for comprehensive GMP audits in the pharmaceutical industry. By integrating interviews with traditional methods, such audits provide deeper insights into ...

SHANGHAI, Aug. 30, 2024 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has ...

May 2026 - Bora Pharmaceuticals ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced that its Board of Directors has approved the acquisition of the GMP manufacturing operations, ...

Detailed price information for Herbal Dispatch Inc (HERB-CN) from The Globe and Mail including charting and trades.

IFPMA, has called for greater inspection reliance between regulatory agencies to help biopharmaceutical companies reduce GMP ...